These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 7903845)
1. Can the H2 receptor antagonists change the natural history of duodenal ulcer disease? Bardhan KD Am J Gastroenterol; 1994 Jan; 89(1):3-6. PubMed ID: 7903845 [No Abstract] [Full Text] [Related]
2. Response to "H2-receptor antagonists and duodenal ulcer recurrence". Kurata JH; Nogawa AN; Koch GG Am J Gastroenterol; 1988 Dec; 83(12):1427-9. PubMed ID: 2904219 [No Abstract] [Full Text] [Related]
3. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer. Thomas JM; Misiewicz G Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417 [No Abstract] [Full Text] [Related]
4. [Histamine H2-receptor antagonists as new anti-ulcer agents]. Takemoto T Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835 [No Abstract] [Full Text] [Related]
5. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists]. Hentschel E Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397 [No Abstract] [Full Text] [Related]
6. Bedtime treatment of duodenal ulcer. Drug Ther Bull; 1985 Dec; 23(24):95-6. PubMed ID: 2866081 [No Abstract] [Full Text] [Related]
7. Ranitidine and cimetidine for duodenal ulcer. Langman MJ; Henry DA; Ogilvie A Scand J Gastroenterol Suppl; 1981 Jun; 69():115-7. PubMed ID: 6119774 [No Abstract] [Full Text] [Related]
8. [Therapy of duodenal ulcer with H2-blockers. 2 x 150 mg ranitidine versus 2 x 400 mg cimetidine]. Hüttemann W Fortschr Med; 1983 Jan; 101(4):139-41. PubMed ID: 6131857 [TBL] [Abstract][Full Text] [Related]
9. [Which drug for peptic ulcer?]. Hameeteman W; Tytgat GN Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643 [No Abstract] [Full Text] [Related]
10. [Pathogenesis, diagnosis and therapy of ulcer disease. Therapy. 4: Pharmacological basis and therapy with H2 antagonist]. Med Welt; 1983 Dec; 34(49):20, 22. PubMed ID: 6140616 [No Abstract] [Full Text] [Related]
11. Maintenance therapy of duodenal ulcer with H2-receptor antagonists--a meta-analysis. Palmer RH; Frank WO; Karlstadt R Aliment Pharmacol Ther; 1990 Jun; 4(3):283-94. PubMed ID: 1983324 [TBL] [Abstract][Full Text] [Related]
12. H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection. Freston JW Am J Gastroenterol; 1987 Dec; 82(12):1242-9. PubMed ID: 2891294 [TBL] [Abstract][Full Text] [Related]
13. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level. Ohsawa T; Hirata W; Higichi S Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773 [TBL] [Abstract][Full Text] [Related]
14. H2-receptor antagonists: development and application. Feldman S N Engl Reg Allergy Proc; 1986; 7(4):362-6. PubMed ID: 2886903 [TBL] [Abstract][Full Text] [Related]
17. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease]. Simon B; Müller P; Dammann HG Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962 [TBL] [Abstract][Full Text] [Related]
18. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models. Del Soldato P; Ghiorzi A; Cereda E; Donetti A Pharmacology; 1985; 30(1):45-51. PubMed ID: 2858110 [TBL] [Abstract][Full Text] [Related]
19. [Ranitidine: an alternative to cimetidine in the treatment of duodenal ulcer]. Simon B; Müller P; Dammann HG; Kather H MMW Munch Med Wochenschr; 1981 Jun; 123(25):1049-50. PubMed ID: 6114426 [No Abstract] [Full Text] [Related]
20. Duodenal ulcer. Who should have long-term maintenance therapy? Zuckerman G Postgrad Med; 1987 Oct; 82(5):52-3, 57-8, 60. PubMed ID: 2890147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]